Saudi SPIMACO, Amgen sign marketing, technology transfer deal
The deal is effective for ten years from the signing date
Mubasher - 29 Apr 2020
Saudi Pharmaceutical Industries and Medical Appliances Corporation (2070.SE)
Also known as: SPIMACO, SPIMACO ADDWAEIH
59.80 SAR 0.000.00%
SPIMACO Stock Price & Performance
Recommendation
-
Div Yield
-
P/E (Last 12 Month)
66.42
Upside
-
Target Price (Mean)
-
Open
Data not available
Previous Close
59.80 SAR
Turnover
Data not available
EPS
0.906 SAR
Volume
0
Transactions
0
Market Cap
7.18B SAR
IPO Date
10-Jan-1999
Analyst Estimates
| EPS | Revenue | |
|---|---|---|
| Mean Estimate |  | |
| Smart Estimate | | |
| Predicted Surprise | | |
| Mean Chg % | | |
Starmine Models
StarMine provides a suite of proprietary alpha-generating analytics and models spanning sectors, regions, and markets.
| Bullish | |
|---|---|
| Value Momentum | |
| Intrinsic Valuation | |
| Relative Valuation | |
| Credit Risk - Smart Ratios | |
| Credit Risk- Text Mining | |
| Bearish | |
|---|---|
| Price Momentum | |
About Saudi Pharmaceutical Industries and Medical Appliances Corporation
Business Summary
Manufacture and distribution of generic and licensed pharmaceuticals and medical supplies. Through its main subsidiaries; distribution of pharmaceutical products; manufacture of medical supplies including gowns, draping packs and sterilization wraps; manufacture of pharmaceutical chemicals including active pharmaceutical ingredients.
Country of Incorporation
Ownership Type
Established In
1986
Primary Sector
Stock Listing
| ID | Stock Type | Currency | Exchange | Symbol |
|---|---|---|---|---|
| 2070.SSE | Ordinary | SAR | Saudi SE | 2070 |
Contact details
Primary address
Building: Building 89Street: Al Ahsa Street
Area: Al Malaz District
P.O. Box: 20001
Country: Saudi Arabia
City: Riyadh
City Suffix: 11455
CONTACT
- Tel: +966 11-252-3333
- Fax: +966 11-252-3300
- Email: general@spimaco.sa
- www.spimaco.com.sa
Region
RiyadhOwnership
Ownership
| Investor | Holding | No. of Shares | Last Update |
|---|---|---|---|
| | | |
| | | |
Holding Concentrations
| Investor | Holding | No. of Shares | Last Update |
|---|---|---|---|
| | | |
| | | |
Financials
Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing
Executives
Dr Mohammed Abdulrahman Mohammed Sultan Al Sultan
Chief Executive Officer
Dr Mohammed Bin Abdulaziz Al Fadli
Deputy Chief Executive Officer, Marketing and Sales
Dr Mahmoud Motlak Sohbi Abdelkhaliq
Chief Financial Officer
Board Members
HE Mohammed Bin Talal Mohammed Al Nahhas
Chairman
Mr Ammar Abdulwahed Faleh Al Khudairy
Vice Chairman
Mr Faisal Mohammed Amin Shaker
Director
Company information provided by Refinitiv
Refinitiv research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).
Zawya Coverage
Abu Dhabi cuts business set-up fees by over 90%
Outlook: Saudi will see stronger Q3 growth as oil, non-oil sectors bounce back
Value of mergers and acquisitions in MENA reached $44.8bln in H1 2021 - Refinitiv
Monday Outlook: Asian stocks sidelined; spreading Delta threatens oil demand
UAE's recovery to gain momentum in H2 as Expo Dubai boosts activity
Monday Outlook: Asian stocks sidelined; spreading Delta threatens oil demand
Gold subdued; dollar holds near multi-months high; Fed meeting in focus
Stock Market Data
Powered By Knowledge Direct